Viewing

Interventional Glaucoma

Latest News



Implanatation of multiple trabecular micro-bypass implants (iStent, Glaukos) in Schlemm's canal following phamoemulsification successfully and significantly reduced IOP for 12 months after implantation, as well as the number of medications required to maintain target IOP

Analyses of data from the Confocal Scanning Laser Ophthalmoscopy Ancilliary Study to the Ocular Hypertension Treatment study found rim area parameters changed significantly in the eyes that had progression to a primary open-angle glaucoma endpoint compared with eyes that did not.

New findings from the ongoing African Descent and Glaucoma Evaluation Study (ADAGES) support previous results indicating that ancestry differences in visual function in healthy eyes are likely to be a sign of early disease.

A glaucoma specialist outlines the seven deadly sins of glaucoma management that, if avoided, can greatly reduce the number of people who go blind from glaucoma. These points include making sure that diagnosis occurs promptly and that patient compliance is stressed.

The French EyeOP1 medical device, from EyeTechCare, is a novel and non-invasive treatment for glaucoma that is based on the use of high-intensity focused ultrasound (HIFUs). The product is set to become available at the end of 2010

Trab-shunt debate

Clinicians pose several arguments for trabeculectomy and tube-shunt surgery

World Glaucoma Day

Glaucoma remains the world's leading cause of irreversible blindness, but 50% of people who have this devastating disease don't know it,” said Dr Clive Midgal, president of the European Glaucoma Society.

The Glaucoma Research Foundation (GRF) awarded the 2010 Shaffer Prize for Innovative Glaucoma Research to Kate Keller, PhD. Dr Keller is Research Assistant Professor, Department of Ophthalmology at Casey Eye Institute in Portland, Oregon.